Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 398

1.

Joint Canadian Association of Gastroenterology and Crohn's Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease.

Moayyedi P, Benchimol EI, Armstrong D, Yuan C, Fernandes A, Leontiadis GI.

J Can Assoc Gastroenterol. 2020 Feb;3(1):e1-e9. doi: 10.1093/jcag/gwz035. Epub 2019 Nov 8. No abstract available.

2.

Reply to GASTRO-D-19-,01448, GASTRO-D-19-01576, GASTRO-D-19-02060, and GASTRO-D-19-02139.

Moayyedi P, Eikelboom J, Yusuf S.

Gastroenterology. 2020 Jan 6. pii: S0016-5085(20)30003-2. doi: 10.1053/j.gastro.2019.12.023. [Epub ahead of print] No abstract available.

PMID:
31917257
3.

Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.

Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, Ford AC.

Lancet Gastroenterol Hepatol. 2020 Feb;5(2):117-131. doi: 10.1016/S2468-1253(19)30324-3. Epub 2019 Dec 16.

PMID:
31859183
4.

Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.

Pittayanon R, Lau JT, Leontiadis GI, Tse F, Yuan Y, Surette M, Moayyedi P.

Gastroenterology. 2019 Dec 5. pii: S0016-5085(19)41893-3. doi: 10.1053/j.gastro.2019.11.294. [Epub ahead of print]

PMID:
31812509
5.

Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem.

Kanno T, Moayyedi P.

Curr Gastroenterol Rep. 2019 Dec 5;21(12):65. doi: 10.1007/s11894-019-0732-3. Review.

PMID:
31807948
6.

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.

Steinhart AH, Panaccione R, Targownik L, Bressler B, Khanna R, Marshall JK, Afif W, Bernstein CN, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C.

J Can Assoc Gastroenterol. 2018 Dec;1(4):141-154. doi: 10.1093/jcag/gwy047. Epub 2018 Sep 14. Review.

7.

Reply.

Moayyedi P, Eikelboom JW, Yusuf S.

Gastroenterology. 2020 Jan;158(1):285-286. doi: 10.1053/j.gastro.2019.10.032. Epub 2019 Nov 5. No abstract available.

PMID:
31704300
8.

Interpreting Reported Risks Associated With Use of Proton Pump Inhibitors: Residual Confounding in a 10-Year Analysis of National Ambulatory Data.

Ma C, Shaheen AA, Congly SE, Andrews CN, Moayyedi P, Forbes N.

Gastroenterology. 2020 Feb;158(3):780-782.e3. doi: 10.1053/j.gastro.2019.10.023. Epub 2019 Oct 31. No abstract available.

PMID:
31678304
9.

Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis.

Eikelboom JW, Connolly SJ, Bosch J, Shestakovska O, Aboyans V, Alings M, Anand SS, Avezum A, Berkowitz SD, Bhatt DL, Cook-Bruns N, Felix C, Fox KAA, Hart RG, Maggioni AP, Moayyedi P, O'Donnell M, Rydén L, Verhamme P, Widimsky P, Zhu J, Yusuf S.

Circulation. 2019 Oct 29;140(18):1451-1459. doi: 10.1161/CIRCULATIONAHA.119.041949. Epub 2019 Sep 12.

PMID:
31510769
10.

Editorial: the overlap between dyspepsia and gastro-oesophageal reflux-is duodenal eosinophilia the missing link?

Kanno T, Moayyedi P.

Aliment Pharmacol Ther. 2019 Aug;50(4):454-455. doi: 10.1111/apt.15388. No abstract available.

PMID:
31359477
11.

Faecal microbiota transplantation for IBS: still a long way to go.

Moayyedi P.

Lancet Gastroenterol Hepatol. 2019 Sep;4(9):656-657. doi: 10.1016/S2468-1253(19)30226-2. Epub 2019 Jul 17. No abstract available.

PMID:
31326346
12.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease.

Mack DR, Benchimol EI, Critch J, deBruyn J, Tse F, Moayyedi P, Church P, Deslandres C, El-Matary W, Huynh H, Jantchou P, Lawrence S, Otley A, Sherlock M, Walters T, Kappelman MD, Sadowski D, Marshall JK, Griffiths A.

Gastroenterology. 2019 Aug;157(2):320-348. doi: 10.1053/j.gastro.2019.03.022. Epub 2019 Jul 15.

PMID:
31320109
13.

Is Blood Urea Concentration an Independent Predictor of Positive Endoscopic Findings in Presumed Upper Gastrointestinal Bleeding?

Chopra D, Rosenberg M, Moayyedi P, Narula N.

Dig Dis. 2020;38(1):77-84. doi: 10.1159/000501549. Epub 2019 Jul 16.

14.

Patient Engagement and Multidisciplinary Involvement Has an Impact on Clinical Guideline Development and Decisions: A Comparison of Two Irritable Bowel Syndrome Guidelines Using the Same Data.

Moayyedi P, Marsiglio M, Andrews CN, Graff LA, Korownyk C, Kvern B, Lazarescu A, Liu L, MacQueen G, Paterson WG, Sidani S, Vanner SJ, Sinclair P, Marshall L, Fernandes A.

J Can Assoc Gastroenterol. 2019 Apr;2(1):30-36. doi: 10.1093/jcag/gwy072. Epub 2019 Jan 17.

15.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS).

Moayyedi P, Andrews CN, MacQueen G, Korownyk C, Marsiglio M, Graff L, Kvern B, Lazarescu A, Liu L, Paterson WG, Sidani S, Vanner S.

J Can Assoc Gastroenterol. 2019 Apr;2(1):6-29. doi: 10.1093/jcag/gwy071. Epub 2019 Jan 17.

16.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease.

Mack DR, Benchimol EI, Critch J, deBruyn J, Tse F, Moayyedi P, Church P, Deslandres C, El-Matary W, Huynh H, Jantchou P, Lawrence S, Otley A, Sherlock M, Walters T, Kappelman MD, Sadowski D, Marshall JK, Griffiths A.

J Can Assoc Gastroenterol. 2019 Aug;2(3):e35-e63. doi: 10.1093/jcag/gwz018. Epub 2018 Jul 10.

17.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.

Panaccione R, Steinhart AH, Bressler B, Khanna R, Marshall JK, Targownik L, Afif W, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C, Bernstein CN.

J Can Assoc Gastroenterol. 2019 Aug;2(3):e1-e34. doi: 10.1093/jcag/gwz019. Epub 2018 Jul 10.

18.

Canadian Association of Gastroenterology Statement on the Putative Link Between Proton Pump Inhibitor Treatment and Gastric Cancer after Helicobacter pylori Eradication.

Leontiadis GI, Veldhuyzen Van Zanten S, Hookey L, Armstrong D, Jones N, Moayyedi P.

J Can Assoc Gastroenterol. 2018 Dec;1(4):155-158. doi: 10.1093/jcag/gwy040. Epub 2018 Jul 17. No abstract available.

19.

Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease.

Turpin W, Espin-Garcia O, Bedrani L, Madsen K, Meddings JB, Raygoza Garay JA, Silverberg MS, Smith MI, Griffiths AM, Moayyedi P, Marshall JK, Mack D, Seidman EG, Ropeleski M, Feagan BG, Jacobson K, Turner D, Walters T, Paterson AD; CCC GEM Project Research Consortium, Xu W, Croitoru K.

Inflamm Bowel Dis. 2019 Oct 18;25(11):1796-1804. doi: 10.1093/ibd/izz116.

PMID:
31251335
20.

Diarrhoea: interventions, consequences and epidemiology in the intensive care unit (DICE-ICU): a protocol for a prospective multicentre cohort study.

Dionne JC, Sullivan K, Mbuagbaw L, Takaoka A, Duan EH, Alhazzani W, Devlin JW, Duprey M, Moayyedi P, Armstrong D, Thabane L, Tsang JLY, Jaeschke R, Hamielec C, Karachi T, Cartin-Ceba R, Muscedere J, Alshahrani MSS, Cook DJ.

BMJ Open. 2019 Jun 27;9(6):e028237. doi: 10.1136/bmjopen-2018-028237.

21.

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S; COMPASS Investigators.

Gastroenterology. 2019 Sep;157(3):682-691.e2. doi: 10.1053/j.gastro.2019.05.056. Epub 2019 May 29.

PMID:
31152740
22.

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Cook Bruns N, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar A, Parkhomenko AN, Ryden L, Pogosova N, Dans A, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik T, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne K, Fox KAA, Yusuf S; COMPASS Investigators.

Gastroenterology. 2019 Aug;157(2):403-412.e5. doi: 10.1053/j.gastro.2019.04.041. Epub 2019 May 2.

PMID:
31054846
23.

Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.

Black CJ, Burr NE, Camilleri M, Earnest DL, Quigley EM, Moayyedi P, Houghton LA, Ford AC.

Gut. 2020 Jan;69(1):74-82. doi: 10.1136/gutjnl-2018-318160. Epub 2019 Apr 17.

PMID:
30996042
24.

Letter: meta-analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors' reply.

Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P.

Aliment Pharmacol Ther. 2019 May;49(9):1254-1255. doi: 10.1111/apt.15234. No abstract available.

PMID:
30977174
25.

Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review.

Pittayanon R, Lau JT, Yuan Y, Leontiadis GI, Tse F, Surette M, Moayyedi P.

Gastroenterology. 2019 Jul;157(1):97-108. doi: 10.1053/j.gastro.2019.03.049. Epub 2019 Mar 30.

PMID:
30940523
26.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.

Panaccione R, Steinhart AH, Bressler B, Khanna R, Marshall JK, Targownik L, Afif W, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C, Bernstein CN.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1680-1713. doi: 10.1016/j.cgh.2019.02.043. Epub 2019 Mar 7.

PMID:
30853616
27.

Response to Letter by Moulton et al.

Narula N, Pinto-Sanchez MI, Calo NC, Ford AC, Bercik P, Reinisch W, Moayyedi P.

Inflamm Bowel Dis. 2019 Jul 17;25(8):e99. doi: 10.1093/ibd/izz035. No abstract available.

PMID:
30824939
28.

Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease.

Narula N, Pinto-Sanchez MI, Calo NC, Ford AC, Bercik P, Reinisch W, Moayyedi P.

Inflamm Bowel Dis. 2019 Jun 18;25(7):1255-1261. doi: 10.1093/ibd/izy385.

29.

Imipramine for functional dyspepsia: a 60-year journey.

Kanno T, Moayyedi P.

Lancet Gastroenterol Hepatol. 2018 Dec;3(12):815-817. doi: 10.1016/S2468-1253(18)30338-8. Epub 2018 Oct 22. No abstract available.

PMID:
30361079
30.

Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials.

Pittayanon R, Yuan Y, Bollegala NP, Khanna R, Lacy BE, Andrews CN, Leontiadis GI, Moayyedi P.

Am J Gastroenterol. 2019 Feb;114(2):233-243. doi: 10.1038/s41395-018-0258-6.

PMID:
30337705
31.

Prokinetics for functional dyspepsia.

Pittayanon R, Yuan Y, Bollegala NP, Khanna R, Leontiadis GI, Moayyedi P.

Cochrane Database Syst Rev. 2018 Oct 18;10:CD009431. doi: 10.1002/14651858.CD009431.pub3.

32.

Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.

Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P.

Aliment Pharmacol Ther. 2018 Nov;48(10):1044-1060. doi: 10.1111/apt.15001. Epub 2018 Oct 8.

PMID:
30294792
33.

Characterization of Simultaneous Pressure Waves as Biomarkers for Colonic Motility Assessed by High-Resolution Colonic Manometry.

Chen JH, Parsons SP, Shokrollahi M, Wan A, Vincent AD, Yuan Y, Pervez M, Chen WL, Xue M, Zhang KK, Eshtiaghi A, Armstrong D, Bercik P, Moayyedi P, Greenwald E, Ratcliffe EM, Huizinga JD.

Front Physiol. 2018 Sep 20;9:1248. doi: 10.3389/fphys.2018.01248. eCollection 2018.

34.

A Comparison of the Prevalence of Anxiety and Depression Between Uncomplicated and Complex IBD Patient Groups.

Yongwen Ng J, Chauhan U, Armstrong D, Marshall J, Tse F, Moayyedi P, Reinisch W, Halder S.

Gastroenterol Nurs. 2018 Sep/Oct;41(5):427-435. doi: 10.1097/SGA.0000000000000338.

PMID:
30272605
35.

Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.

Ford AC, Lacy BE, Harris LA, Quigley EMM, Moayyedi P.

Am J Gastroenterol. 2019 Jan;114(1):21-39. doi: 10.1038/s41395-018-0222-5.

36.

Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.

Black CJ, Burr NE, Quigley EMM, Moayyedi P, Houghton LA, Ford AC.

Gastroenterology. 2018 Dec;155(6):1753-1763. doi: 10.1053/j.gastro.2018.08.021. Epub 2018 Aug 23.

37.

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.

Steinhart AH, Panaccione R, Targownik L, Bressler B, Khanna R, Marshall JK, Afif W, Bernstein CN, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C.

Inflamm Bowel Dis. 2019 Jan 1;25(1):1-13. doi: 10.1093/ibd/izy247.

PMID:
30099529
38.

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial.

Jankowski JAZ, de Caestecker J, Love SB, Reilly G, Watson P, Sanders S, Ang Y, Morris D, Bhandari P, Brooks C, Attwood S, Harrison R, Barr H, Moayyedi P; AspECT Trial Team.

Lancet. 2018 Aug 4;392(10145):400-408. doi: 10.1016/S0140-6736(18)31388-6. Epub 2018 Jul 26. Erratum in: Lancet. 2018 Dec 15;392(10164):2552.

39.

A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome.

Dionne J, Ford AC, Yuan Y, Chey WD, Lacy BE, Saito YA, Quigley EMM, Moayyedi P.

Am J Gastroenterol. 2018 Sep;113(9):1290-1300. doi: 10.1038/s41395-018-0195-4. Epub 2018 Jul 26.

40.

Proton pump inhibitors and gastric cancer: association is not causation.

Moayyedi P, Veldhuyzen van Zanten SJO, Hookey L, Armstrong D, Jones N, Leontiadis GI.

Gut. 2019 Aug;68(8):1529-1530. doi: 10.1136/gutjnl-2018-316958. Epub 2018 Jul 13. No abstract available.

PMID:
30006494
41.

Update on Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Disease.

Moayyedi P.

Gastroenterol Hepatol (N Y). 2018 May;14(5):319-322. No abstract available.

42.

American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome.

Ford AC, Moayyedi P, Chey WD, Harris LA, Lacy BE, Saito YA, Quigley EMM; ACG Task Force on Management of Irritable Bowel Syndrome.

Am J Gastroenterol. 2018 Jun;113(Suppl 2):1-18. doi: 10.1038/s41395-018-0084-x. No abstract available.

43.

FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects.

Turpin W, Bedrani L, Espin-Garcia O, Xu W, Silverberg MS, Smith MI, Guttman DS, Griffiths A, Moayyedi P, Panaccione R, Huynh H, Steinhart H, Aumais G, Shestopaloff K, Dieleman LA, Turner D, Paterson AD, Croitoru K.

Gut Microbes. 2018 Jul 4;9(4):357-368. doi: 10.1080/19490976.2018.1445956. Epub 2018 Apr 27.

44.

Response to Marlicz et al.

Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N.

Am J Gastroenterol. 2018 May;113(5):781. doi: 10.1038/s41395-018-0034-7. Epub 2018 Mar 9. No abstract available.

PMID:
29523865
45.

Reply.

Pinto Sanchez MI, Moayyedi P, Bercik P.

Gastroenterology. 2018 Feb;154(3):764-765. doi: 10.1053/j.gastro.2018.01.022. Epub 2018 Jan 17. No abstract available.

PMID:
29351832
46.

Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis.

Jarde A, Lewis-Mikhael AM, Moayyedi P, Stearns JC, Collins SM, Beyene J, McDonald SD.

BMC Pregnancy Childbirth. 2018 Jan 8;18(1):14. doi: 10.1186/s12884-017-1629-5. Review.

47.

Proton Pump Inhibitors and Dementia: Deciphering the Data.

Moayyedi P, Lewis MA.

Am J Gastroenterol. 2017 Dec;112(12):1809-1811. doi: 10.1038/ajg.2017.415.

PMID:
29215629
48.

Signature Celebration of Gastroenterology, Colorectal Cancer.

Chan AT, Moayyedi P.

Gastroenterology. 2018 Mar;154(4):767-770. doi: 10.1053/j.gastro.2017.11.029. Epub 2017 Nov 24. No abstract available.

PMID:
29174953
49.

Proton pump inhibitors for functional dyspepsia.

Pinto-Sanchez MI, Yuan Y, Hassan A, Bercik P, Moayyedi P.

Cochrane Database Syst Rev. 2017 Nov 21;11:CD011194. doi: 10.1002/14651858.CD011194.pub3. Review.

50.

Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice.

Moayyedi P, Mearin F, Azpiroz F, Andresen V, Barbara G, Corsetti M, Emmanuel A, Hungin APS, Layer P, Stanghellini V, Whorwell P, Zerbib F, Tack J.

United European Gastroenterol J. 2017 Oct;5(6):773-788. doi: 10.1177/2050640617731968. Epub 2017 Sep 28. Review.

Supplemental Content

Loading ...
Support Center